Annals of Surgery Open (Sep 2021)

Resectability of Pancreatic Cancer Is in the Eye of the Observer

  • Fabio Giannone, MD,
  • Giovanni Capretti, MD,
  • Mohammed Abu Hilal, MD, PhD,
  • Ugo Boggi, MD,
  • Donata Campra, MD,
  • Carla Cappelli, MD,
  • Riccardo Casadei, MD,
  • Raffaele De Luca, MD,
  • Massimo Falconi, MD,
  • Gabriele Giannotti, MD,
  • Luca Gianotti, MD,
  • Roberto Girelli, MD,
  • Paola Gollini, MD,
  • Davide Ippolito, MD,
  • Giorgio Limerutti, MD,
  • Lorenzo Maganuco, MD,
  • Valeria Malagnino, MD,
  • Giuseppe Malleo, MD, PhD,
  • Mario Morone, MD,
  • Cristina Mosconi, MD,
  • Federica Mrakic, MD,
  • Diego Palumbo, MD,
  • Roberto Salvia, MD, PhD,
  • Salvatore Sgroi, MD,
  • Alessandro Zerbi, MD,
  • Gianpaolo Balzano, MD

DOI
https://doi.org/10.1097/AS9.0000000000000087
Journal volume & issue
Vol. 2, no. 3
p. e087

Abstract

Read online

Objectives:. To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. Background:. The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular invasion. It is used to recommend different approaches and stratify patients during clinical trials. Methods:. Prospective, multicenter, observational study (trial ID: NCT03673423). Main outcome measure was the interobserver agreement of tumor assignment to different resectability classes and quantification of vascular invasion degrees. Agreement was measured by Fleiss’ k (k = 1 perfect agreement; k = 0 agreement by chance). Sixty-nine computed tomography (CT) scans of pathologically confirmed pancreatic adenocarcinoma were independently reviewed in a blinded fashion by 22 observers from 11 hospitals (11 surgeons and 11 radiologists). Rating differences between surgeons or radiologists and between hospitals with different volumes (≥60 or 180° (k range: 0.619–0.756). Neither reviewers’ specialty nor hospital volume influenced the agreement. Conclusions:. There is high variability in the assignment to resectability categories, which may compromise the reliability of treatments recommendations and the evidence of trials stratifying patients in resectability classes. Criteria should be revised to allow a reproducible classification.